PIN4 COST-BENEFIT ANALYSIS OF OSELTAMIVIR VERSUS NO ANTIVIRAL TREATMENT FROM THE EMPLOYER PERSPECTIVE:THE ROCHE BRAZIL CASE
AC Moreno, MG Saggia, EA Santos, S RodriguesVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65511-8
File:
PDF, 74 KB
english, 2007